课题基金 / 基金详情

CHARACTERIZATION OF THE FACTOR VIII IN FACTOR VIII CONCENTRATES

CHARACTERIZATION OF THE FACTOR VIII IN FACTOR VIII CONCENTRATES
因子 VIII 浓缩物中因子 VIII 的表征
批准号:
3792653
负责人:
W FRICKE
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

W FRICKE的其他基金

相似基金

相关文献

中文摘要
翻译
因子VIII浓缩物中的因子VIII的特点是
英文摘要
The factor VIII in factor VIII concentrates is being characterized by activity and antigen assays and by immunoblotting. The availability of factor VIII concentrates of increasing purity, including recombinant factor VIII, has raised concern about potency testing and potential immunogenicity resulting in increased numbers of hemophiliacs who form antibodies to factor VIII used as therapy. The potency of these products can be influenced by the state of activation of the factor VIII. This activated state can possibly be detected by the presence of factor VIII fragments known to be formed by thrombin cleavage, by an increase in activity relative to antigen, or by assays relatively specific for activated factor VIII. All factor VIII concentrates available in the U.S. or under review by FDA for licensure are being studied in an attempt to characterize their factor VIII and determine if there are differences among then in activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EPITOPE MAPPING OF ANTIBODIES TO VON WILLEBRAND FACTOR
ACTIVATION OF FVIII BY FXA AND INHIBITION BY TISSUE FACTOR PATHWAY INHIBITOR
EPITOPE MAPPING OF ANTIBODIES TO FACTOR VIII
EPITOPE MAPPING OF FACTOR VIII AND VON WILLEBRAND FACTOR
  • 批准号:
    3770445
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    W FRICKE
  • 依托单位:
    --
海外基金